BioCardia, Inc. (BCDA)
NASDAQ: BCDA · Real-Time Price · USD
2.100
-0.170 (-7.49%)
At close: Apr 3, 2025, 4:00 PM
2.400
+0.300 (14.29%)
Pre-market: Apr 4, 2025, 8:47 AM EDT

BioCardia Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Revenue
0.060.481.351.020.15
Upgrade
Revenue Growth (YoY)
-87.84%-64.72%33.20%600.00%-79.58%
Upgrade
Cost of Revenue
4.397.738.838.569.81
Upgrade
Gross Profit
-4.33-7.25-7.48-7.54-9.67
Upgrade
Selling, General & Admin
3.674.44.425.095.86
Upgrade
Operating Expenses
3.674.44.425.095.86
Upgrade
Operating Income
-8-11.64-11.9-12.63-15.53
Upgrade
Interest Expense
-----0
Upgrade
Interest & Investment Income
0.060.07--0.02
Upgrade
Other Non Operating Income (Expenses)
---0.010.01-0
Upgrade
EBT Excluding Unusual Items
-7.95-11.57-11.91-12.62-15.51
Upgrade
Other Unusual Items
----0.51
Upgrade
Pretax Income
-7.95-11.57-11.91-12.62-15
Upgrade
Net Income
-7.95-11.57-11.91-12.62-15
Upgrade
Net Income to Common
-7.95-11.57-11.91-12.62-15
Upgrade
Shares Outstanding (Basic)
31111
Upgrade
Shares Outstanding (Diluted)
31111
Upgrade
Shares Change (YoY)
94.32%19.52%4.75%67.19%79.27%
Upgrade
EPS (Basic)
-2.90-8.19-10.08-11.19-22.24
Upgrade
EPS (Diluted)
-2.90-8.19-10.08-11.19-22.24
Upgrade
Free Cash Flow
-8.03-9.99-10.63-10.48-12.39
Upgrade
Free Cash Flow Per Share
-2.93-7.07-9.00-9.29-18.37
Upgrade
Operating Margin
-13794.83%-2441.09%-880.25%-1244.34%-10709.65%
Upgrade
Profit Margin
-13700.00%-2425.79%-880.70%-1243.64%-10347.59%
Upgrade
Free Cash Flow Margin
-13848.28%-2093.50%-786.32%-1032.71%-8544.14%
Upgrade
EBITDA
-7.93-11.56-11.82-12.57-15.46
Upgrade
D&A For EBITDA
0.070.080.080.060.07
Upgrade
EBIT
-8-11.64-11.9-12.63-15.53
Upgrade
Revenue as Reported
--1.351.020.15
Upgrade
Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q